Is early response by 18 F-2-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography a predictor of long-term outcome in patients with metastatic colorectal cancer?

Journal of Gastrointestinal Oncology

Celso Abdon Lopes de Mello¹  Aldo Lourenço Abadde Dettino¹  Maria Nirvana da Cruz Formiga¹  Marcello Ferretti Fanelli¹  Eduardo Nóbrega Pereira Lima²  Marcelo Cavicchioli²  Ulisses Ribaldo Nicolau¹ 

[1] Department of Medical Oncology,AC Camargo Cancer Center, São Paulo, SP, BrazilDepartment of Medical Oncology,AC Camargo Cancer Center, São Paulo, SP, BrazilDepartment of Medical Oncology,AC Camargo Cancer Center, São Paulo, SP, Brazil;Department of Radiology and Nuclear Medicine, AC Camargo Cancer Center, São Paulo, SP, BrazilDepartment of Radiology and Nuclear Medicine, AC Camargo Cancer Center, São Paulo, SP, BrazilDepartment of Radiology and Nuclear Medicine, AC Camargo Cancer Center, São Paulo, SP, Brazil

关键词: Metabolic response;    colorectal cancer (CRC);    positron emission tomography;   

DOI  :  10.21037/jgo.2016.02.04

学科分类：肿瘤学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown